-
2
-
-
0030776457
-
Acquired hemophilia and its treatment
-
Sultan Y (1997) Acquired hemophilia and its treatment. Blood Coagul Fibrinolysis 8(Suppl 1):15S-18S
-
(1997)
Blood Coagul Fibrinolysis
, vol.8
, Issue.SUPPL. 1
-
-
Sultan, Y.1
-
3
-
-
0033768130
-
The diagnosis and management of factor VIII and IX inhibitors: A guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO)
-
Hay CRM, Baglin TP, Collins PW, Hill FGH, Keeling DM (2000) The diagnosis and management of factor VIII and IX inhibitors: A guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO). Br J Haematol 111:78-90
-
(2000)
Br J Haematol
, vol.111
, pp. 78-90
-
-
Hay, C.R.M.1
Baglin, T.P.2
Collins, P.W.3
Hill, F.G.H.4
Keeling, D.M.5
-
4
-
-
0035010280
-
Postpartum acquired haemophilia: Clinical recognition and management
-
Kashyap R, Choudhry VP, Mahapatra M, Chumber S, Saxena R, Kaul HL (2001) Postpartum acquired haemophilia: Clinical recognition and management. Haemophilia 7:327-330
-
(2001)
Haemophilia
, vol.7
, pp. 327-330
-
-
Kashyap, R.1
Choudhry, V.P.2
Mahapatra, M.3
Chumber, S.4
Saxena, R.5
Kaul, H.L.6
-
6
-
-
0035199305
-
Inhibitor treatment: State of the art
-
Shapiro A (2001) Inhibitor treatment: State of the art. Semin Hematol 38:26-34
-
(2001)
Semin Hematol
, vol.38
, pp. 26-34
-
-
Shapiro, A.1
-
7
-
-
0037394016
-
Acquired haemophilia: Review and meta-analysis focused on therapy and prognostic factors
-
Delgado J, Yimenez-Yuste V, Hernandez-Navarro F, Villar A (2003) Acquired haemophilia: Review and meta-analysis focused on therapy and prognostic factors. Br J Haematol 121:21-35
-
(2003)
Br J Haematol
, vol.121
, pp. 21-35
-
-
Delgado, J.1
Yimenez-Yuste, V.2
Hernandez-Navarro, F.3
Villar, A.4
-
8
-
-
0020662181
-
The use of factor eight inhibitor by-passing activity (FEIBA Immuno) product for treatment of bleeding episodes in hemophiliacs with inhibitors
-
FEIBA Study Group
-
Hilgartner MW, Knatterud GL, FEIBA Study Group (1983) The use of factor eight inhibitor by-passing activity (FEIBA Immuno) product for treatment of bleeding episodes in hemophiliacs with inhibitors. Blood 61:36-40
-
(1983)
Blood
, vol.61
, pp. 36-40
-
-
Hilgartner, M.W.1
Knatterud, G.L.2
-
9
-
-
0032837867
-
The use of agents that by-pass factor VIII inhibitors in patients with hemophilia
-
Roberts HR (1999) The use of agents that by-pass factor VIII inhibitors in patients with hemophilia. Vox Sang 77(Suppl 1):38-41
-
(1999)
Vox Sang
, vol.77
, Issue.SUPPL. 1
, pp. 38-41
-
-
Roberts, H.R.1
-
10
-
-
0030700329
-
The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: A multicenter study
-
Hay CRM, Negrier C, Ludlam CA (1997) The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: A multicenter study. Thromb Haemost 78:1463-1467
-
(1997)
Thromb Haemost
, vol.78
, pp. 1463-1467
-
-
Hay, C.R.M.1
Negrier, C.2
Ludlam, C.A.3
-
11
-
-
33846669469
-
Tyr2105Cys mutation in exon 22 of FVIII gene is a risk factor for the development of inhibitors in patients with mild/moderate haemophilia
-
Franchini M, Girelli D, Olivieri O et al (2006) Tyr2105Cys mutation in exon 22 of FVIII gene is a risk factor for the development of inhibitors in patients with mild/moderate haemophilia A. Haemophilia 12:448-451
-
(2006)
A Haemophilia
, vol.12
, pp. 448-451
-
-
Franchini, M.1
Girelli, D.2
Olivieri, O.3
|